Kush Parmar - Insider Trading & Ownership

Location: C/O 5 Am Venture Management, Llc, 4 Embarcadero Center, Suite 3110, San Francisco, CA
Summary: The estimated net worth of Kush Parmar is at least $36.3M dollars as of November 18, 2025. Kush Parmar is the Director, 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $32.8M. Kush Parmar is the Director, 10%+ Owner of Vor Biopharma Inc. and owns shares of Vor Biopharma Inc. (VOR) stock worth about $3.22M. Kush Parmar is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $242K. Kush Parmar is the Director of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $29.2K.
Signature: /s/ Kush Parmar
All Insider Reports: All Insider Reports

Email me when Kush Parmar files a new Ownership 3,4,5 report.

Ownership of Kush Parmar

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TRDA	Entrada Therapeutics, Inc.	Director, 10%+ Owner	$32.8M	-$2.83M	-7.93%	Nov 14, 2025
VOR	Vor Biopharma Inc.	Director, 10%+ Owner	$3.22M			Jun 14, 2022
QTTB	Q32 Bio Inc.	Director	$242K			Jun 15, 2022
RLYB	Rallybio Corp	Director	$29.2K			May 15, 2024
AKUS	Akouos, Inc.	Director, 10%+ Owner				Nov 30, 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.